KO Client Pluto Biosciences Raises $3.6 Million

KO client Pluto Bio, the leading AI-powered platform for computational biology, recently raised $3.6 million in new funding to accelerate growth and scale adoption of its enterprise-grade platform among global pharma companies.

According to the announcement, the round includes participation from new investor Kickstart, alongside existing investor Silverton Partners and existing angel investors.

“With this funding, we’re fueling our mission to make high-dimensional biological data accessible to the people who deeply understand the underlying biology and unmet therapeutic needs,” said Dr. Rani Powers, Founder and CEO of Pluto, in the announcement. “Teams using Pluto are already demonstrating that innovation in drug discovery accelerates when scientists can directly generate insights from complex data. Our platform was built to make that vision real, whether for a team of ten scientists or an enterprise organization with hundreds.”

KO partner Kevin Gibson, attorney John Kyed, and paralegal Sara Richissin represented Pluto Bio in the financing. Learn more in the announcement.